Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K103574
    Date Cleared
    2011-07-28

    (234 days)

    Product Code
    Regulation Number
    862.1155
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    Lehnus & Associates Consulting

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Pregnancy One Step Rapid Test Strip is an in vitro diagnostic visual qualitative immunochromatographic assay designed for the rapid determination of human chorionic gonadotropin (hCG) in urine to aid in the early detection of pregnancy. For professional use only.

    The Pregnancy One Step Rapid Test Cassette is an in vitro diagnostic visual qualitative immunochromatographic assay designed for the rapid determination of human chorionic gonadotropin (hCG) in urine to aid in the early detection of pregnancy. For professional use only.

    The Pregnancy One Step Rapid Midstream Test is an in vitro diagnostic visual qualitative immunochromatographic assay designed for the rapid determination of human chorionic gonadotropin (hCG) in urine to aid in the early detection of pregnancy. For OTC self-testing use.

    Device Description

    Not Found

    AI/ML Overview

    The provided document is a 510(k) clearance letter from the FDA for a family of Pregnancy One Step Rapid Tests (Strip, Cassette, Midstream). It states that the FDA has reviewed the premarket notification and determined the device to be "substantially equivalent" to legally marketed predicate devices.

    However, this document does not contain the acceptance criteria, details of the study, reported device performance, sample sizes, ground truth establishment, or expert qualifications that would be found in a detailed study report. The FDA clearance letter primarily confirms the device's substantial equivalence to existing devices based on the information submitted by the manufacturer. It does not typically include the raw performance data or a detailed breakdown of the studies conducted by the manufacturer.

    Therefore, I cannot extract the requested information from the provided text. The document confirms the FDA's regulatory clearance but does not present the underlying study data and acceptance criteria in the format requested.

    Ask a Question

    Ask a specific question about this device

    K Number
    K052359
    Date Cleared
    2005-10-03

    (38 days)

    Product Code
    Regulation Number
    862.1205
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    Lehnus & Associates Consulting

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The IBL Cortisol Luminescence Immunoassay is for the in-vitro-diagnostic quantitative determination of cortisol in human serum and saliva.

    The Cortisol LIA kit is useful as an aid in the differential diagnosis of Cushing syndrome and Addison's disease.

    Device Description

    IBL Cortisol LIA test kit

    AI/ML Overview

    This is an FDA Premarket Notification (510(k)) letter for the IBL Cortisol LIA test kit. The letter itself does not contain the detailed acceptance criteria or the study results. It primarily states that the device has been found substantially equivalent to a predicate device.

    Therefore, I cannot provide the requested information from the provided text because it is not present in this document. The document confirms that the device is cleared for marketing but does not detail the technical performance studies and acceptance criteria that led to that clearance.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1